Lifestyle Natural Medicines
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
(marketscreener.com) Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced that the initiati
Silence Therapeutics plc, Nasdaq: SLN (Silence or the Company), an experienced and innovative biotechnology company committed to transforming peoples lives by silencing diseases through precision eng… [+5278 chars]
Related
Share this page
Guest Posts by Easy Branches